ProShares

Join ProShares Global Investment Strategist Simeon Hyman and his team for a look at why so many covered call ETFs fall behind when stocks rise, and how newer approaches aim to strike a better balance between income and long-term equity potential.

The Federal Reserve cut its Fed Funds rate by 25 bps, the 10-year Treasury yield went up 10 bps, and the S&P 500 ended the month of October up over 2%. Let’s unpack those results.

Federal Reserve Chairman Jerome Powell caught everyone's attention when he cast doubt on a December rate cut. It’s easy to see why. Standard Fed logic is simple: 2, 3, 4.

Investors can be forgiven their skepticism towards small caps, despite the current rally. After all, small caps have underperformed the top-heavy, large-cap S&P 500 over the last decade.

As we write this, the market’s reaction to the government shutdown in the U.S. has been little more than a shoulder shrug. That would seem a rational response, particularly if this shutdown is short-lived.

Gold has climbed steadily higher over the past year. And the August attempt to fire Fed governor Lisa Cook seemed to catalyze what has since been a steep price rally.

The Fed has made its first rate cut of the year, with more possibly ahead—but that doesn’t mean longer-term yields like the 10-year Treasury will follow. So far, they haven’t. The potential result? A frustrating mix of falling money market rates and stagnant at best bond prices. For yield-seeking investors, equity income strategies may offer a compelling alternative, with opportunities less sensitive to interest rate swings.

Growth and income funds have a dual mandate to target both capital appreciation and current income, typically generated through dividends or interest payments.

Making the case for potential rate cuts in his recent speech at Jackson Hole, Fed Chair Powell noted that policy is presently in restrictive territory.

A powerful equity market rebound has pushed stocks to all-time highs, leaving investors elated but cautious amid lingering uncertainties.

It is easy to invest when markets are rallying, but it can be tough for investors to stay in their seats when markets inevitably decline again.

Surprisingly, oil prices are receding after U.S. strikes on Iranian nuclear facilities over the weekend.

While the immediate path for tariffs may drift lower, the U.S. legislative branch is hammering out a tax and spending bill that seems to favor tax cuts over lower spending, reviving worries over the U.S. budget deficit and a growing debt burden that cannot be ignored.

Moody’s Friday downgrade of the U.S. credit rating may not seem particularly earthshaking, given that Fitch and Standard & Poor’s had gotten there quite a while ago.

By the end of April, the S&P 500 rallied its way back, recovering nearly all the declines notched in the opening days of the month when President Trump's "Liberation Day" tariff plans tipped markets towards bear territory.

Roughly a month on from Liberation Day one thing is clear: While actual tariff numbers may not be set, markets have certainly been liberated from complacency. S

The announcement of global tariffs by President Trump has rocked markets and much is uncertain, but there are key facts for investors to keep in mind.

News related to tariffs, DOGE, geopolitical unrest, NVIDIA earnings, and more significantly impacted U.S. stock markets recently, with the S&P 500 retreating over 2.5% during the second half of February. There are signs that meaningful structural shifts are taking place in the market.

U.S. equity investors face an interesting allocation question in 2025: Why buy anything other than the S&P 500?

In this article, we will demonstrate how the use of daily options within a covered call strategy has the potential to generate substantial income while also targeting the total return of equities.

Investors, many of whom were worried about stock valuations before the election, have much to consider heading into 2025. There seems reason for some exuberance—but a rational exuberance, based upon a plausible foundation of corporate and economic health.